Edgewise Therapeutics, Inc. EWTX 深 沪
已收盘 10-16 16:00:00 美东时间
37.19
-1.010
-2.64%
华盛通- 最 高38.28
- 今 开38.28
- 成交量 130.55万股
- 最 低 36.70
- 昨 收 38.20
- 总市值 40.39亿
- 52周最高 48.51
- 市盈率 静 --
- 换手率 1.20%
- 52周最低 15.23
- 委 比 -33.33%
- 总股本 1.09亿
- 历史最高 48.51
- 量 比 0.98
- 振 幅 4.14%
- 历史最低 5.12
- 每 手 1
- 风险率 8.21%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Edgewise Therapeutics收跌2.64%，成交额4249.43万美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
今天 05:11
William Blair Initiates Coverage On Edgewise Therapeutics with Outperform Rating
William Blair analyst Alethia Young initiates coverage on Edgewise Therapeutics (NASDAQ:EWTX) with a Outperform rating.
10-16 23:05
Edgewise Therapeutics Doses First Participant In EQUINOX-HFpEF Study Of EDG-15400 To Treat Adults With Symptomatic Heart Failure With Preserved Ejection Fraction
Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading clinical-stage biopharmaceutical company focused on cardiometabolic diseases, today announced the dosing of the first patient in EQUINOX-HFpEF, a Phase 2 clinical trial evaluating EDG-15400 in adults with symptomatic heart failure with preserved ...
10-08 20:07
Edgewise Therapeutics Doses First Patient in Phase 2 EQUINOX-HFpEF Trial of EDG-15400
– Phase 2 trial evaluating EDG-15400 in adults with symptomatic HFpEF with a LVEF of at least 50% – – EQUINOX-HFpEF trial design and EDG-15400 Phase 1 first-in-human data to be presented at ...
10-08 20:00
美股大行评级 | 麦当劳目标价遭下调至320美元！现价仍有近3成上涨空间；戴尔、迈威尔、微软齐获机构看好
今日重点评级关注：HC Wainwright & Co.：维持Gossamer Bio"买入"评级，目标价从2美元升至90美元；巴克莱：维持Ultragenyx Pharmaceutical"超配"评级，目标价从32美元升至35美元
09-22 16:25
HC Wainwright & Co. Maintains Buy on Edgewise Therapeutics, Raises Price Target to $57
HC Wainwright & Co. analyst Lander Egaña Gorroño maintains Edgewise Therapeutics (NASDAQ:EWTX) with a Buy and raises the price target from $45 to $57.
09-21 18:43
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
BOULDER, Colo., Sept. 2, 2026 /PRNewswire/ -- Edgewise Therapeutics, Inc. ("Edgewise" or the "Company"), (Nasdaq: EWTX), a leading clinical-stage biopharmaceutical company focused on cardiov...
09-02 20:00
美股夜盘 | Vista Oil & Gas小升3.41%，劳埃德小升3.30%
Vista Oil & Gas小升3.41%；劳埃德小升3.30%；Edgewise Therapeutics, Inc.小升2.97%
08-19 13:01
美股夜盘 | Vista Oil & Gas上升4.12%，劳埃德上升3.30%
Vista Oil & Gas上升4.12%；劳埃德上升3.30%；Keysight Technologies Inc上升2.98%
08-19 10:01
美股夜盘 | Vista Oil & Gas大升5.85%，劳埃德上升3.30%
Vista Oil & Gas大升5.85%；劳埃德上升3.30%；Edgewise Therapeutics, Inc.上升2.97%
08-19 09:01
